Clinical Trial Update: Efficacy and Safety of Alogliptin Used Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan [Phase 2, Phase 3]

View source ↗

Summary

This trial update reports the efficacy and safety results of combining alogliptin with a thiazolidinedione in participants with Type 2 diabetes in Japan (Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Alogliptin (alogliptin)
• Thiazolidinedione (thiazolidinedione)

Snippet

Sponsor: Takeda | Conditions: Type 2 Diabetes Mellitus | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2011-07-06